![]() |
|
|
Vol. 303, Issue 3, 1121-1129, December 2002
Department of Pharmacology (L.J.C.B., D.J.J., D.C.M.) and Division
of Nephrology, Department of Medicine (A.K.G.), Medical University of
South Carolina, Charleston, South Carolina; and Research Service
(A.K.G.), Ralph H. Johnson Veteran's Administration Medical Center,
Department of Veteran's Affairs, Charleston, South Carolina
Primaquine is an important antimalarial drug that is often dose-limited
in therapy by the onset of hemolytic anemia. We have shown recently
that an N-hydroxy metabolite of primaquine,
6-methoxy-8-hydroxylaminoquinoline (MAQ-NOH), is a direct-acting
hemolytic agent in rat red cells and that the hemolytic activity of
this metabolite is associated with GSH oxidation and oxidative damage
to both membrane lipids and skeletal proteins. To determine whether the
formation of free radicals may be involved in this process, rat red
cells (40% suspensions) were incubated with hemolytic concentrations
of MAQ-NOH (150-750 µM) and examined by EPR spectroscopy using
2-ethoxycarbonyl-2-methyl-3,4-dihydro-2H-pyrrole-1-oxide (EMPO) as a spin trap. Addition of MAQ-NOH to red cell suspensions containing 10 mM EMPO gave rise to an EPR spectrum with hyperfine constants consistent with those of an EMPO-hydroxyl radical adduct standard. Of interest, formation of EMPO-OH was constant for up to 20 min and dependent on the presence of erythrocytic GSH. Although no
other radical adduct signals were detected in the cells by EPR,
spectrophotometric analysis revealed the presence of ferrylhemoglobin, which indicates that hydrogen peroxide is generated under these experimental conditions. The data support the hypothesis that oxygen-derived and possibly other free radicals are involved in the
mechanism underlying MAQ-NOH-induced hemolytic anemia.
This article has been cited by other articles:
![]() |
N. P. D. Nanayakkara, A. L. Ager Jr., M. S. Bartlett, V. Yardley, S. L. Croft, I. A. Khan, J. D. McChesney, and L. A. Walker Antiparasitic Activities and Toxicities of Individual Enantiomers of the 8-Aminoquinoline 8-[(4-Amino-1-Methylbutyl)Amino]-6-Methoxy-4-Methyl-5-[3,4-Dichlorophenoxy]Quinoline Succinate Antimicrob. Agents Chemother., June 1, 2008; 52(6): 2130 - 2137. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. S. Bowman, J. D. Morrow, D. J. Jollow, and D. C. McMillan Primaquine-Induced Hemolytic Anemia: Role of Membrane Lipid Peroxidation and Cytoskeletal Protein Alterations in the Hemotoxicity of 5-Hydroxyprimaquine J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 838 - 845. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. S. Bowman, J. E. Oatis Jr., J. L. Whelan, D. J. Jollow, and D. C. McMillan Primaquine-Induced Hemolytic Anemia: Susceptibility of Normal versus Glutathione-Depleted Rat Erythrocytes to 5-Hydroxyprimaquine J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 79 - 85. [Abstract] [Full Text] |
||||